Find trials
Search tips

Immunofluorescence Diagnostic Test for the Diagnosis of Primary Ciliary Dyskinesia

Overview

About this study

The purpose of this studty is to demonstrate the role of immunofluorescence testing in the diagnosis of Primary Ciliary Dyskenisia through development and performance of the immunofluorescence test.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Patients with known PCD or being investigated for the diagnosis of PCD.

Exclusion Criteria: 

  • < 18 years of age.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 3/21/2024. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Marie Christine Aubry, M.D.

Contact us for the latest status

Contact information:

Thoracic Surgery Research Unit

(877) 526-9172

More information

Publications

Publications are currently not available

More about research at Mayo Clinic

.
CLS-20569492

Mayo Clinic Footer